XML 21 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Net Loss Per Share
3 Months Ended
Mar. 31, 2020
Net Loss Per Share  
Net Loss Per Share

10. Net Loss Per Share

 

Basic net loss per share was calculated as follows for the three months ended March 31, 2020 and 2019. 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 

 

    

2020

 

    

2019

Numerator:

 

 

 

 

 

 

Net loss attributable to common stockholders

 

$

(21,512)

 

$

(17,124)

Denominator:

 

 

  

 

 

 

Weighted average common shares outstanding, basic

 

 

51,900,882

 

 

42,251,292

Net loss per share attributable to common stockholders, basic

 

$

(0.41)

 

$

(0.41)

 

 

 

 

 

 

 

 

For the three months ended March 31, 2020 there is no dilutive impact. Therefore, diluted net loss per share is the same as basic net loss per share. Diluted net loss per share was calculated as follows for the three months ended March  31, 2019:

 

 

 

 

 

 

Three Months Ended March 31, 

 

    

2019

Net loss attributable to common stockholders, basic

$

(17,124)

Interest expense on 2026 Convertible Notes

 

356

Change in fair value of derivative liability

 

(3,223)

Net loss attributable to common stockholders, diluted

$

(19,991)

 

 

 

Weighted average common shares outstanding, basic

 

42,251,292

Shares issuable upon conversion of 2026 Convertible Notes, as if converted

 

1,923,077

Weighted average common shares outstanding, diluted

 

44,174,369

 

 

 

Net loss per share attributable to common stockholders, diluted

 

(0.45)

 

The Company excluded the following common stock equivalents, outstanding as of March 31, 2020 and 2019, from the computation of diluted net loss per share for the three months ended March 31, 2020 and the three months ended March 31, 2019 because they had an anti-dilutive impact.  The Company also excluded the shares issuable upon conversion of the 2026 Convertible notes from the computation of diluted net loss per share for the three months ended March 31, 2020 because they had an anti-dilutive impact.

 

 

 

 

 

 

 

 

As of March 31, 

 

    

2020

    

2019

Options to purchase common stock

 

9,292,354

 

7,296,948

Warrants for the purchase of common stock

 

18,939

 

18,939

 

 

9,311,293

 

7,315,887